@article{schmitt_siegel_selle_2024, title={Applications of designer phage encoding recombinant gene payloads}, volume={42}, ISSN={["1879-3096"]}, DOI={10.1016/j.tibtech.2023.09.008}, abstractNote={<h2>Abstract</h2> Advances in genetic engineering, synthetic biology, and DNA sequencing have transformed the re-emergent therapeutic bacteriophage field. The increasing rate of multidrug resistant (MDR) infections and the speed at which new bacteriophages can be isolated, sequenced, characterized, and engineered has reinvigorated phage therapy and unlocked new applications of phages for modulating bacteria. The methods used to genetically engineer bacteriophages are undergoing significant development, but identification of heterologous gene payloads with desirable activity and determination of their impact on bacteria or human cells in translationally relevant applications remain underexplored areas. Here, we discuss and categorize recombinant gene payloads for their potential outcome on phage–bacteria interactions when genetically engineered into phage genomes for expression in their bacterial hosts.}, number={3}, journal={TRENDS IN BIOTECHNOLOGY}, author={Schmitt, Daniel S. and Siegel, Sara D. and Selle, Kurt}, year={2024}, month={Mar}, pages={326–338} }